Respiratory Medicine
Volume 103, Issue 8 , Pages 1224-1230 , August 2009

Clinical predictors of the efficacy of a pulmonary rehabilitation programme in patients with COPD

Received 20 August 2008 ,Accepted 27 January 2009.

References 

  1. Nici L, Donner C, Wouters E, et al. American Thoracic Society/European Respiratory Society Statement on Pulmonary Rehabilitation. Am J Respir Crit Care Med. 2006;173:1390–1413
  2. Hill NS. Pulmonary rehabilitation. Proc Am Thorac Soc. 2006;3:66–74
  3. Vogiatzis I, Williamson AF, Miles J, Taylor IK. Physiological response to a moderate exercise workload in a pulmonary rehabilitation programme in patients with varying degrees of airflow obstruction. Chest. 1999;116:1200–1207
  4. Couser JI, Guthmann R, Hamadeh MA, Kane CS. Pulmonary rehabilitation improves exercise capacity in older elderly patients with COPD. Chest. 1995;107:730–734
  5. Foster S, Lopez D, Thomas HM. Pulmonary rehabilitation in COPD patients with elevated CO2. Am Rev Respir Dis. 1988;138:1519–1523
  6. Wedzicha JA, Bestall JC, Garrod R, et al. Randomized controlled trial of pulmonary rehabilitation in severe chronic obstructive pulmonary disease patients, stratified with the MRC dyspnoea scale. Eur Respir J. 1998;12:363–369
  7. Garrod R, Marshall J, Barley E, Jones PW. Predictors of success and failure in pulmonary rehabilitation. Eur Respir J. 2006;27:788–794
  8. St Buchi, Villiger B, Sensky T, et al. Psychosocial predictors of long-term success of in-patient pulmonary rehabilitation of patients with COPD. Eur Respir J. 1997;10:1272–1277
  9. Young P, Dewse M, Kolbe J. Respiratory rehabilitation in chronic obstructive pulmonary disease: predictors of nonadherence. Eur Respir J. 1999;13:855–885
  10. Landbo C, Prescott E, Lange P, et al. Prognostic value of weight change in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1999;160:1856–1861
  11. Celli BR, Cote CG, Marin JM, et al. The body-mass index, airflow obstruction, dyspnoea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med. 2004;350:1005–1012
  12. Curkendall SM, Deluise C, Jones JK, et al. Cardiovascular disease in patients with chronic obstructive pulmonary disease, Saskatchewan Canada cardiovascular disease in COPD patients. Ann Epidemiol. 2006;16:63–70
  13. Berger JS, Sanborn TA, Sherma W, Brown DL. Effect of chronic obstructive pulmonary disease on survival of patients with coronary heart disease having percutaneous coronary intervention. Am J Cardiol. 2004;94:649–651
  14. Sin DD, Wu L, Man SF. The relationship between reduced lung function and cardiovascular mortality: a population-based study and a systematic review of literature. Chest. 2005;127:1952–1959
  15. Crisafulli E, Costi S, Luppi F, et al. Role of comorbidities in a cohort of patients with COPD undergoing pulmonary rehabilitation. Thorax. 2008;63:487–492
  16. Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Workshop report. Publication number 2710; update 2006.
  17. American Thoracic Society . Standardization of spirometry: 1994 update. Am J Respir Crit Care Med. 1995;152:1107–1136
  18. ATS/ACCP . Statement on cardiopulmonary exercise testing. Am J Respir Crit Care Med. 2003;167:211–277
  19. American Thoracic Society. ATS Statement . Guidelines for the six-minute walk test. Am J Respir Crit Care Med. 2002;166:111–117
  20. Jones PW, Quirk FH, Baveystock CM, Littlejohns P. A self-completed measure of health status for chronic airflow limitation. Am Rev Respir Dis. 1992;145:1321–1327
  21. Laviolette L, Bourbeau J, Bernard S, et al. Assessing the impact of pulmonary rehabilitation in functional status in COPD. Thorax. 2008;63:115–121
  22. O'Donnell DE, Revill S, Webb KA. Dynamic hyperinflation and exercise tolerance in COPD. Am J Respir Crit Care Med. 2001;164:770–777
  23. Sauleda J, Garcia-Palmer FJ, Wiesner R, et al. Cytochrome oxidase activity and mitochondrial gene expression in skeletal muscle of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1998;157:1791–1797
  24. Anthonisen NR, Connet JE, Kiley JP, et al. Effects of smoking intervention and the use of an anticholinergic bronchodilators on the decline of FEV1. The Lung Health Study. JAMA. 1994;272:1497–1505
  25. Koenig SM. Pulmonary complications of obesity. Am J Med Sci. 2001;321:249–279
  26. Ramachandran K, McCusker C, Connors M, Zuwallack R, Lahiri B. The influence of obesity on pulmonary rehabilitation outcomes in patients with COPD. Chron Respir Dis. 2008;5:205–209
  27. Emtner M, Porszasz J, Burns M, Somfay A, Casaburi R. Benefits of supplemental oxygen in exercise training in nonhypoxemic Chronic Obstructive Pulmonary Disease patients. Am J Respir Crit Care Med. 2003;168:1034–1042
  28. Garrod R, Paul EA, Wedzicha JA. Supplemental oxygen during pulmonary rehabilitation in patients with COPD with exercise hypoxemia. Thorax. 2000;55:539–543
  29. Brusasco V, Pellegrino R. Oxygen in the rehabilitation of patients with chronic obstructive pulmonary disease: an old tool revisited. Am J Respir Crit Care Med. 2003;168:1021–1022

PII: S0954-6111(09)00039-0

doi: 10.1016/j.rmed.2009.01.023

Respiratory Medicine
Volume 103, Issue 8 , Pages 1224-1230 , August 2009

Article Tools

* Image Usage & Resolution